A Placebo-Controlled Double-Blind Comparative Study of CNTO1275 in Patients With Plaque Type Psoriasis
Phase of Trial: Phase III
Latest Information Update: 02 Jul 2014
At a glance
- Drugs Ustekinumab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Janssen Pharmaceutical KK
- 01 Sep 2012 Quality-of-life effects published in the Journal of Dermatology.
- 01 Mar 2012 Results published in the Journal of Dermatology.
- 26 May 2011 Results presented at the World Congress of Dermatology (WCD) in May 2011.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History